Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Pfizer Ltd - 500680 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2021

 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, we submit herewith the unaudited financial results for the quarter and half year ended September 30, 2021, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 4.00 p.m. and concluded at 6.00 p.m. Also please find enclosed the Limited Review Report by our Auditors M/s. Walker Chandiok & Co LLP, in respect of the above results. Please take the above on record.
03-11-2021

Third Pfizer vax dose more effective in reducing severe Covid: Lancet

 A third vaccine dose of Pfizer-BioNTech is effective in reducing severe Covid related outcomes compared to individuals who have received two vaccine doses at least five months ago, finds a new study.
31-10-2021
Bigul

FDA paves way for Pfizer Covid-19 vaccinations in young kids

 The FDA has cleared kid-size doses just a third of the amount given to teens and adults
30-10-2021

Pfizer gets US contract for 50 mn COVID-19 vaccine doses for kids

 The drugmakers said they expect initial clinical trial data on the vaccine's use in children -- aged 2 to less than 5 years, and 6 months to less than 2 years -- is expected in the fourth quarter this year or early first quarter of 2022.
28-10-2021

US FDA advisers back Pfizer/BioNTech COVID-19 vaccine for children

 An authorization for that age group would be would be an important regulatory step toward reaching about 28 million children for inoculation, most of them back in school for in-person learning.
27-10-2021
Bigul

Pfizer Ltd - 500680 - Board Meeting Intimation for Board Meeting For Consideration And To Take On Record The Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2021.

 PFIZER LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2021 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, November 3, 2021, inter alia, to consider and take on record the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021. Pursuant to the 'Pfizer Limited - Code of Internal Procedures and Conduct to Regulate, Monitor and Report Trading by Insiders', the Trading Window of the Company was closed from Thursday, September 30, 2021 (close of business) till 48 hours after the results are made public on November 3, 2021. We request you to kindly take the same on record.
25-10-2021
Bigul

FDA says Pfizer Covid vaccine looks effective for young kids

 Agency will wait for its panel of independent advisers to meet next Tuesday before making its own decision
23-10-2021

Benefits of Pfizer child shot likely outweigh risks, FDA says

 According to the staff report, which was posted on the FDA website late Friday, the vaccine's capacity to prevent hospitalizations and deaths likely exceed the risk of adverse outcomes such as the heart condition myocarditis, which has been reported in some younger males who have received messenger RNA shots for Covid-19.
23-10-2021

US authorizes 'mix and match' Covid vaccine boosters: Regulator

 The Pfizer, Moderna, and Johnson Johnson vaccines are authorized in the United States. A single dose of any of them may now be used following completion of primary vaccination with a different Covid vaccine.
21-10-2021
Bigul

Pfizer Ltd - 500680 - Statement Of Investor Complaints For The Quarter Ended September 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 043430 Name of the Signatory :- PRAJEET NAIRDesignation :- Company Secretary and Compliance Officer
21-10-2021
Next Page
Close

Let's Open Free Demat Account